A new phase-contrast CR mammography system that magnifies edge effects from x-ray refraction is sharpening contrast at the edges of the breast. The system, unveiled today at the RSNA meeting, also enhances the visualization of microcalcifications and fibrils within the breast, according to representatives from Konica Minolta.
A new phase-contrast CR mammography system that magnifies edge effects from x-ray refraction is sharpening contrast at the edges of the breast. The system, unveiled today at the RSNA meeting, also enhances the visualization of microcalcifications and fibrils within the breast, according to representatives from Konica Minolta.
The Regius PureView Mammography System combines phase-contrast mammography technology with computed radiography to produce digital mammography images with the same resolution as screen-film images.
The device uses a molybdenum x-ray tube with a 100-micron focal spot. The system also selects the optimal combination of x-ray focal spot size, the distance between the x-ray source and the breast, the distance between the x-ray source and the detector, and the sampling pitch of the CR reader, which scans images at 43.75 micrometers to produce a resolution of 20 line pair per millimeter.
The CR mammography system, which was introduced 10 months ago in Japan, is being tested in clinical trials prior to submission to the FDA for approval.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.